News
A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...
This inhibition results in an increase in local concentrations of adenosine which acts on the platelet A2-receptor thereby stimulating platelet adenylate cyclase and increasing platelet cyclic-3 ...
Founded in 2017, Cell Receptor is collaborating with universities to extend knowledge and research in this area. Actively growing tumor cells have platelet receptors on their surface. These ...
Platelets circulate within the whole body and exert two principle functions: protection against bleeding and invading pathogens. Their multiple antimicrobial facets are beneficial, such as direct ...
Hosted on MSN3mon
FDA accepts Sobi North America’s thrombocytopenia therapy sNDAfor receptor binding. It functions by stimulating the growth of megakaryocytes, which are bone marrow cells responsible for platelet production. An autoimmune disorder, ITP leads to lower platelet ...
A research team from MedUni Vienna/University Hospital Vienna, the Dana-Farber Cancer Institute and the University of Michigan Medical School identified Platelet-Derived Growth Factor Receptor ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results